Re: new fda approved drug for folliculities

That is very interesting and really hopeful news. I did some reading and it appears Orbactiv is both antibacterial and antifungal both primary causes of follicultis. The FDA just approved similar drugs Dalvance (dalbavancin) in May and June approval of Sivextro (tedizolid).

http://www.medicinenet.com/script/main/art.asp?articlekey=179938 Tweet